Wall Street brokerages expect Leidos Holdings Inc (NYSE:LDOS) to report sales of $2.64 billion for the current quarter, according to Zacks. Four analysts have provided estimates for Leidos’ earnings, with the highest sales estimate coming in at $2.65 billion and the lowest estimate coming in at $2.62 billion. Leidos reported sales of $2.50 billion in the same quarter last year, which indicates a positive year over year growth rate of 5.6%. The company is expected to report its next earnings results on Thursday, November 1st.
According to Zacks, analysts expect that Leidos will report full-year sales of $10.31 billion for the current fiscal year, with estimates ranging from $10.24 billion to $10.35 billion. For the next year, analysts expect that the firm will post sales of $10.79 billion per share, with estimates ranging from $10.64 billion to $11.00 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Leidos.
Leidos (NYSE:LDOS) last released its quarterly earnings data on Thursday, July 26th. The aerospace company reported $1.12 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.05 by $0.07. The company had revenue of $2.53 billion during the quarter, compared to the consensus estimate of $2.57 billion. Leidos had a net margin of 4.42% and a return on equity of 18.05%. Leidos’s revenue for the quarter was down 1.6% on a year-over-year basis. During the same period last year, the firm earned $1.04 EPS.
Several research firms have issued reports on LDOS. Zacks Investment Research upgraded shares of Leidos from a “sell” rating to a “hold” rating in a research note on Wednesday, June 6th. ValuEngine upgraded shares of Leidos from a “hold” rating to a “buy” rating in a research note on Friday, May 11th. Finally, Goldman Sachs Group cut shares of Leidos from a “buy” rating to a “neutral” rating in a research note on Monday, June 18th. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. Leidos presently has a consensus rating of “Buy” and a consensus target price of $75.13.
NYSE LDOS traded up $0.22 on Friday, hitting $70.95. The stock had a trading volume of 478,900 shares, compared to its average volume of 961,791. Leidos has a 52-week low of $55.76 and a 52-week high of $72.30. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.31 and a quick ratio of 1.08. The stock has a market capitalization of $10.65 billion, a PE ratio of 18.98, a P/E/G ratio of 1.69 and a beta of 1.67.
The company also recently announced a quarterly dividend, which will be paid on Friday, September 28th. Shareholders of record on Monday, September 17th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 1.80%. The ex-dividend date of this dividend is Friday, September 14th. Leidos’s dividend payout ratio is presently 34.41%.
A number of hedge funds and other institutional investors have recently bought and sold shares of LDOS. First Command Bank purchased a new stake in Leidos in the 2nd quarter worth approximately $106,000. First Command Financial Services Inc. purchased a new stake in shares of Leidos during the 2nd quarter valued at $106,000. Braun Bostich & Associates Inc. purchased a new stake in shares of Leidos during the 2nd quarter valued at $112,000. Fort L.P. purchased a new stake in shares of Leidos during the 2nd quarter valued at $119,000. Finally, Gables Capital Management Inc. purchased a new stake in shares of Leidos during the 1st quarter valued at $120,000. Institutional investors and hedge funds own 74.19% of the company’s stock.
Leidos Company Profile
Leidos Holdings, Inc provides services and solutions in the defense, intelligence, civil, and health markets primarily in the United States. The company operates through three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Story: Stop Order
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Leidos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leidos and related companies with MarketBeat.com's FREE daily email newsletter.